Wednesday, June 6, 2007

Big managed care study backs Avandia, Glaxo says

(Reuters) - The findings from an analysis of a managed care database of more than 33,000 diabetes patients taking the drug as part of their daily routine, rather than in a clinical trial, were published online in Pharmacoepidemiology and Drug Safety.



The study looked at the incidence of hospitalisations for heart attack and for a surgery known as revascularisation among patients on Avandia. Glaxo had said last week that the paper was due to be published soon.


Read more at Reuters.com Government Filings News

No comments: